Search - tctmd.com

Displaying 441 - 460 of 537

Sort: Relevancy | Date

News Conference News ACC 2019

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

Shelley Wood

March 26, 2019

News Conference News ACC 2019

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

Michael O'Riordan

March 25, 2019

News Daily News

FDA Approves the Optimizer Smart Implantable Pulse Generator for Heart Failure

Yael L. Maxwell

March 22, 2019

News Conference News ACC 2019

CardioMEMS Postapproval Study Linked to Reduction in Heart Failure Hospitalizations at 1 Year

Yael L. Maxwell

March 20, 2019

News Conference News ACC 2019

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

Shelley Wood

March 17, 2019

News Daily News

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Shelley Wood

February 26, 2019

News Industry News

Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

February 25, 2019

News Daily News

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

L.A. McKeown

January 17, 2019

News Daily News

Artificial Intelligence From ECGs May ID Asymptomatic LV Dysfunction

Todd Neale

January 09, 2019

News Daily News

MitraClip Analysis Highlights Questions of Patient Selection in Functional MR

Shelley Wood

January 04, 2019

News Features

Top News in Heart Failure: 2018

Shelley Wood

December 28, 2018

News Conference News AHA 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Michael O'Riordan

November 16, 2018

News Conference News AHA 2018

Remission, Not Cure: No Weaning Off Meds for Dilated Cardiomyopathy Patients, Says TRED-HF

Shelley Wood

November 11, 2018

News Conference News AHA 2018

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

Michael O'Riordan

November 11, 2018

News Daily News

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

Shelley Wood

November 02, 2018

News Daily News

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

L.A. McKeown

November 02, 2018

News Features

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Michael O'Riordan

October 29, 2018

News Daily News

Dapagliflozin Gets Partial Win in DECLARE-TIMI 58

Todd Neale

October 02, 2018

Presentation TCT Abstracts Posters 2018

Coronary Artery Calcium in Heart Failure with Preserved Ejection Fraction Patients: More Serious Than We Think

Presenter: Abdalla Hassan

September 25, 2018

News Conference News TCT 2018

Denervation Has Possible Benefit for Pulmonary Hypertension Related to Left Heart Failure

Todd Neale

September 23, 2018

Advertisement

New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin

PIONEER-HF Extension Study Further Supports Starting Sacubitril/Valsartan in the Hospital

FDA Approves the Optimizer Smart Implantable Pulse Generator for Heart Failure

CardioMEMS Postapproval Study Linked to Reduction in Heart Failure Hospitalizations at 1 Year

COAPT Echo Substudy in HF Patients With Mitral Regurgitation Offers New Answers, and More Questions

How HF Drugs Help and Harm Female Patients: A Call for Sex-Specific Reporting

Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patients With Heart Failure

‘Watchful Waiting’ Tied to Poor Long-term Outcomes in Patients With Severe AR, Analysis Suggests

Artificial Intelligence From ECGs May ID Asymptomatic LV Dysfunction

MitraClip Analysis Highlights Questions of Patient Selection in Functional MR

Top News in Heart Failure: 2018

EMPA-HEART Offers Mechanistic Clues for Empagliflozin’s Cardiac Benefits

Remission, Not Cure: No Weaning Off Meds for Dilated Cardiomyopathy Patients, Says TRED-HF

PIONEER-HF: Sacubitril/Valsartan Safe and Effective in Acute Decompensated Heart Failure

NIH Presses Pause on Cardiac Stem Cell Trial, Further Muddying a Murky Field

Novel Interatrial Shunt Shows Promise at 1 Year in HF Patients With Reduced and Preserved EF

Country Roads: Vulnerable West Virginia Heart Patients Targeted in Outreach Program

Dapagliflozin Gets Partial Win in DECLARE-TIMI 58

Coronary Artery Calcium in Heart Failure with Preserved Ejection Fraction Patients: More Serious Than We Think

Denervation Has Possible Benefit for Pulmonary Hypertension Related to Left Heart Failure

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content